Release Details

vTv Therapeutics to Present at Two Investor Conferences in March

March 4, 2016
PDF Version

HIGH POINT, N.C.--(BUSINESS WIRE)--Mar. 4, 2016-- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease and diabetes, today announced that Stephen Holcombe, President and CEO and Dr. Larry Altstiel, EVP, Chief Medical Officer, will present a corporate overview at two investor conferences in March.

Presentation Details:

Cowen and Company 36th Annual Health Care Conference

  • Location: Boston, MA
  • Presentation Date: Tuesday, March 8, 2016
  • Presentation Time: 9:20am ET

28th Annual ROTH Conference

  • Location: Dana Point, CA
  • Presentation Date: Tuesday, March 15, 2016
  • Presentation Time: 5:30pm PT

Live webcasts of the presentations can be accessed on the News & Events section of the website. The webcasts will be archived for 30 days following the presentations on the Company’s website at www.vtvtherapeutics.com.

About vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and Type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness.

Source: vTv Therapeutics Inc.

Investors
The Trout Group
Adam Krop, 646-378-2963
akrop@troutgroup.com
or
Media
BMC Communications
Brad Miles, 646-513-3125
bmiles@bmccommunications.com